Literature DB >> 6132636

Comparison of pharmacological and binding assays for ten beta-adrenoceptor blocking agents and two beta-adrenoceptor agonists.

N Bieth, B Rouot, J Schwartz, J Velly.   

Abstract

1 The inhibition constants evaluated by binding assays for ten beta-adrenoceptor blocking agents and two beta-adrenoceptor agonists, were compared with the pA2 and pD2 values determined in vitro and in vivo. 2 There was only a limited correlation between beta 1 or beta 2 selectivities observed with the different methods. 3 Selectivity is generally less pronounced in binding assays than for in vivo and in vitro experiments.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6132636      PMCID: PMC2044216          DOI: 10.1111/j.1476-5381.1980.tb14572.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Binding of iodinated beta adrenergic antagonists to proteins derived from rat heart.

Authors:  T K Harden; B B Wolfe; P B Molinoff
Journal:  Mol Pharmacol       Date:  1976-01       Impact factor: 4.436

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes.

Authors:  D C U'Prichard; D B Bylund; S H Snyder
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

4.  Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies.

Authors:  E L Rugg; D B Barnett; S R Nahorski
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436

5.  Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species.

Authors:  S R Nahorski
Journal:  Eur J Pharmacol       Date:  1978-10-01       Impact factor: 4.432

6.  The actions of selective beta-receptor antagonists on the guinea pig trachea.

Authors:  B Levy; B E Wilkenfeld
Journal:  Eur J Pharmacol       Date:  1970-07-01       Impact factor: 4.432

7.  Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.

Authors:  D Horii; T Kawada; K Takeda; S Imai
Journal:  Arzneimittelforschung       Date:  1974-09

8.  Cardiac effects of beta-adrenergic receptor antagonists.

Authors:  B Ablad; B Carlsson; E Carlsson; C Dahlöf; L Ek; E Hultberg
Journal:  Adv Cardiol       Date:  1974

9.  Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog.

Authors:  J L Willems; M G Bogaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  4 in total

1.  Possible activation of intracellular beta-adrenoceptors by extraneuronally accumulated isoprenaline in perfused rat heart.

Authors:  T Magaribuchi; K Kurahashi; M Fujiwara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

2.  Relationship between in vitro relaxation of the costo-uterine smooth muscle and mesovarial leiomyoma formation in vivo by beta-receptor agonists.

Authors:  W E Colbert; B F Wilson; P D Williams; G D Williams
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.

Authors:  G Engel; D Hoyer; R Berthold; H Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

4.  Blood pressure reflexes following activation of capsaicin-sensitive afferent neurones in the biliopancreatic duct of rats.

Authors:  T Griesbacher
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.